Clinical trial
Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard…
NCT00391391 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00391391 |
|---|---|
| Title | Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Infants and Children |
| Official title | Immunogenicity and Safety of a Split, Inactivated, Trivalent Influenza Vaccine Administered by Intradermal Route in Comparison With Intramuscular Vaccination With Standard Fluzone® in Healthy Infants and Young Children. |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Orthomyxoviridae Infection, Influenza, Myxovirus Infection |
| Intervention type | Biological |
| Interventions | Split, Inactivated, Trivalent Influenza Vaccine, Trivalent Influenza Vaccine ( Fluzone® 2006/2007 Formulation) |
| Enrollment | 520 |
| Start date | Oct 1, 2006 |
| Primary completion | Mar 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Oct 24, 2006 |
| Last update posted | Dec 1, 2011 |
| Countries | United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: